pfizer | Al Majalla

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken in Medford, Massachusetts, U.S., May 12, 2022. REUTERS/Brian Snyder/Illustration

U.S. Government to Test Pfizer's Paxlovid For Long COVID

The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID,…

27 October 2022

Pfizer To Supply Up To 6 mln COVID Pill Courses For Lower Income Countries

Pfizer Inc (PFE.N) said it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seek to address worldwide disparities…

23 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

A portrait of a soldier in Beirut, Lebanon.

Alamy

Politics

The Lebanese army can confront Hezbollah. Here's how.

02 September 2025

Lebanon's president and prime minister have a big decision to make: whether, and how, to use the army to disarm Hezbollah. Today's army can be trusted, but its task must be well thought through.

Bilal Saab

Opinion

'The Voice of Hind Rajab' shows cries for justice are only getting louder

07 September 2025

A 24-minute standing ovation at the film premiere was more than a symbolic gesture of justice for Israel's murder of little Hind, but a heartfelt cry of real anguish over the ongoing genocide in Gaza

Samer Abou Hawwach

Al Majalla

Politics

Hugs and hand-holding: Modi sends signals to Trump in Tianjin

06 September 2025

With Modi keen to stand his ground against Trump's tariffs, and India-China relations beginning to thaw, the SCO summit gave New Delhi an opportunity to assert its diplomatic weight

Shakir Husain

Al Majalla

Business & Economy

How Saudi Arabia is redefining the global mining map

06 September 2025

The Future Minerals Forum has become one of the world's most influential gatherings in the minerals sector, uniting stakeholders around the shared goal of building sustainable mineral supply chains

Faisal Faeq